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Abstract
Background: The role of  lateral retroperitoneoscopic adrenalectomy (LRA) for complicated tumor with large diameter remains 
controversial, this study aimed to evaluate the effectiveness of  this procedure on the management of  tumor larger than 5cm in 
diameter.
Methods: A retrospective comparison was conducted of  67 patients with large complicated adrenal tumor (>5cm). 41 patients 
received LRA, and 26 received open adrenalectomy (OA) in our hospital between January 2011 and June 2015. Basic characteris-
tics regarding mean age, gender, body mass index (BMI), tumor size, tumor side, previous abdominal surgery, resection method, 
pathology were preferentially analyzed. Operative indicators regarding operation time, estimated blood loss (EBL), conversion 
to ICU, complications, post-operative hospitalization, duration of  drain, time to first oral intake and ambulation were compared 
between groups.
Results: There were no significant differences between the two groups in the basic characteristics. The mean operation time for 
LRA was shorter than OA (98.7±32.3 min vs 152.7±72.3 min, P = 0.001). EBL was 31.9±20.0 ml for LRA and 590.0±1181.1 ml 
for OA (P = 0.03). There was no complication in LRA group and one patient in OA group had complications, but this difference 
was not significant (P = NS). The post-operative hospitalization in LRA was 7.4±2.8 days, and shorter than 9.8±2.7 days in OA 
group (P = 0.00). The time to first oral intake and ambulation for LRA was shorter than OA (first oral intake, 1.9±0.8 days vs 
3.1±1.3 days, P = 0.00; time to ambulation, 2.6±1.4 days vs 4.2±1.6 days, P = 0.00). While the difference between groups were 
not significant in terms of  ICU conversion (3/41 vs 4/26, P = NS) and duration of  drain (3.9±2.2 days vs 4.7±1.9 days, P = NS).
Conclusion: Our study shows that LRA can be performed safely and effectively for complicated adrenal tumors larger than 5 
cm in diameter, but it remains technically demanding.
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Introduction
Since the endoscopic technique was first introduced to 
perform adrenalectomy in 19921, several approaches 
of  laparoscopic adrenalectomy have been widely used 
in the treatment of  the vast majority of  benign adrenal 
tumors2-6. Among the various approaches, the retroperi-
tonoscopy was widely accepted due to the direct vision. 
While due to the limited space of  posterior peritoneum, 
the indications of  this approach was also confined to 
small adrenal tumors.
Satisfactory clinical results of  lateral retroperitoneoscopic 
adrenalectomy (LRA) have been reported in small adrenal 
tumors7-9, while there is a paucity of  data on the large or 
malignant adrenal tumors10. In the last decades of  20th 
century, Henry11 presented a successful case series of  
patients who received retroperitoneoscopic adrenalecto-
my, with potential malignant and large diameter adrenal 
tumors. However, different opinion has existed in some 
surgeons. Due to the narrow working space, many schol-
ars tend to choose an open or transperitoneal approach to 
deal with large adrenal tumors12-14.
The aim of  this study was to compare the operative out-
come of  LRA versus open surgery in the treatment of  
patients with large diameter (≥ 5cm) complicated adrenal 
tumors.
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Patients and methods
The prospectively maintained urology database in the 
department of  urology at Zigong No.4 people’s hospital 
was retrospectively reviewed to collect data on the large 
diameter complicated adrenal tumor patients who under-
went LRA or open surgery, from January 2011 to June 
2015. There were 67 patients with adrenal tumor larger 
than 5cm. Of  the 67 cases, 41 (26 male and 15 female) 
underwent LRA and the other 26 (13 male and 13 fe-
male) underwent open procedure. All of  the patients re-
ceived complete laboratory examination, which involved 
plasma metanephrines, aldosterone, renin and the aldo-
sterone/renin ratio (ARR), vanilmandelic acid (VMA), 
17-hydroxycorticosteroids (17-OHCS), and 17-keto-ste-
roid (17-KS). Image evaluations such as computed to-
mography (CT) were used to determine the localization 
and diameter of  adrenal mass. Open surgery was used 
in patients with local lymph invasion or periadrenal in-
volvement according to the radiographic evidence. All of  
the patients were provided operative informed consent, 
which mentioned the benefits and potential risks of  pro-
posed operation method. For patients proposed to LRA, 
we also informed them that the open conversion might 
be chosen once any difficulties were encountered during 
the operation.
Surgical technique
According to the different surgical methods, all the pa-
tients were divided into LRA group and open adrenalec-
tomy group (OA). A 30-degree laparoscope was used as 
observation mirror though a 10 mm trocar, the other two 
trocars were located in anterior axillary line and posterior 
axillary line of  subcostal space with a diameter in 5 mm 
or 10 mm (Figure 1). 
Figure 1. Trocar port placement: (1) 10mm port for camera, (2) 
and (3) 5mm port for forceps manipulators.
Ultrasonic shears were used to divide and identify the 
edge of  adrenal gland. The adrenal central vein was di-
vided between hem-o-lok clips. After the adrenal was dis-
sected completely, a self-made bag was used to dress up 
the adrenal gland via a 10 mm trocar into the peritoneal 
cavity. The mass was cut and examined on the operation 
table to ensure the entire tumor was involved. If  it is 
necessary, a hand-assisted retroperitonoscopic adrenalec-
tomy (HARA) was used in the LRA group, which was 
placed at the intersection of  mid-axillary line and subcos-
tal area (Figure 2). 
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After the adrenal area  was exposed, special attention 
would be given to evaluate the tumor location and wheth-
er there is periadrenal involvement. In both the LRA 
and OA group, the main principle was resection with as 
much peri-adrenal tissue as possible to ensure the highest 
negative margin rate. Drainage tube was routinely placed 
before operation was complete. All the procedures were 
performed by senior experienced laparoscopic surgeons 
to reduce the selective bias.
Post-operative management
Routinely, the patients were put in the post-anesthesia 
care unit (PACU) until the blood pressure and heart rate 
were stable, and the patients had regained consciousness 
after surgery. Patients with significant bleeding or labile 
blood pressure were converted to intensive care unit 
(ICU). After approximately thirty minutes’ post-oper-
ative monitoring in PACU, patients were transferred to 
urology department for half  to one day’s electrocardi-
ography monitoring. 24 hours to two days’ fasting was 
needed to help the bowel function recovery. During this 
period, post-operative intravenous fluid supplement was 
used in all the patients. Post-operative hypotension would 
be timely corrected, and this could have been caused by 
the bleeding or inadequate intravenous fluids supplement 
during the intra- or post-operative; fortunately, there was 
no patient who required this management. Patients were 
discharged after adequate pain control and the drainage 
tube was extubated. In addition, patients received regular 
diet and normal ambulation as regards to the requirement 
condition to achieve discharge standard.
Outcome definition
To evaluate the efficacy of  LRA and OA, both the in-
tra-operative terms and post-operative terms were need-
ed. The intra-operative terms included; operation time, 
estimated blood loss (EBL), complications and number 
of  ICU conversions. The post-operative terms included; 
hospitalization, duration of  drain, time to first oral intake 
and time to first ambulation.
Additionally, basic characteristics was preferentially an-
alyzed to assess the balance and comparability between 
two groups, which covered mean age, gender, body mass 
index (BMI), tumor size, tumor side, previous abdominal 
surgery, resection method and pathology type.
Statistical analysis
All the continuous data was expressed as mean ± stan-
dard deviation; discontinuous data was presented as per-
centage. Statistical analyses were performed using SPSS 
version 20.0 (SPSS Inc, Chicago, IL). Two independent 
sample t tests were used in the continuous variables, and 
the Chi-square tests were used in the discontinuous vari-
ables. Curve estimations were used to explore the correla-
tion between diameter and other potential factors. The 
estimating model included linear, logarithmic, inverse, 
quadratic, cubic, compound, power, s curve, growth curve 




Sixty seven adrenalectomies were performed between 
Figure 2. The incision was marked as “L” for hand-assisted 
retroperitonoscopic adrenalectomy.
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Table 2. Operative and postoperative outcomes comparison between groups 
 
  Total LRA OA P value 
No. of patients 67 41 26   
Convert to ICU 7 3 4 0.42 
Complication 1 0 1 0.39 
Operation time 121.9±60.9 98.7±32.3 152.7±72.3 0.001 
Estimated blood loss 418.8±125.9 31.9±20.0 590.0±118.1 <0.001 
Hospitalization 8.3±3.0 7.4±2.8 9.8±2.7 <0.001 
Duration of drain 4.2±2.1 3.9±2.2 4.7±1.9 0.18 
First oral intake 2.4±1.2 1.9±0.8 3.1±1.3 <0.001 
Time to ambulation 3.2±1.7 2.6±1.4 4.2±1.6 <0.001 
ICU, intensive care unit; LRA, retroperitoneoscopic adrenalectomy; OA, open adrenalectomy 
 
Table 1. Basic characteristics comparison between groups. 
 
  Total LRA OA P value 
No. of patients 67 41 26   
Mean age (yrs) 42.3±13.9 44.4±38.9 39.1±15.6 0.13 
BMI (kg/m2) 23.3±2.1 23.5±2.4 22.7±1.6 0.08 
Tumor size (cm) 6.9±2.7 5.8±1.1 7.6±2.4 0.56 
Gender       0.28 
Male 39 26 13   
Female 28 15 13   
Localization       0.07 
Left           40              29             41  
     
Right 25 11 14   
Bilateral 2 1 1   
Previous abdominal surgery 1 1 0 0.42 
Resection       0.33 
Total 41 27 14   
Partial 26 14 12   
Pathology       0.31 
Adrenocortical hyperplasia 23 10 13   
Aldosterone-producing adenoma 26 18 8   
Adrenal medullary hyperplasia 1 1 0   
Adrenal myelolipoma 1 1 0   
Adrenocortical carcinoma 3 2 1   
Adrenal cyst 3 3 0   
Hematoma 3 1 2   
Pheochromocytoma 7 5 2   
             
                   BMI, body mass index; LRA, retroperitoneoscopic adrenalectomy; OA, open adrenalectomy 
  
January 2011 and June 2015 at Zigong No.4 people’s 
hospital. Of  these, 41 patients underwent LRA and 26 
patients underwent OA. The mean age for all cases was 
42.3±13.9 years and there were 39 (58.2%) males. The 
mean tumor size was 6.9±2.7 cm. Tumor localization and 
peritoneal invasion of  each patient was previously eval-
uated by CT scan. There were 40 cases (59.7%) of  left 
localization of  tumor, and tumors in two cases (2.99%) 
were bilateral. Of  the patients, 49 cases (73.1%) had the 
diagnosis of  aldosterone-producing adenoma or adreno-
cortical hyperplasia, 7 cases (10.4%) had the diagnosis of  
pheochromocytoma. There were 3 cases (4.5%) of  he-
matoma and adrenal cyst.  In the case series, there was 
1 adrenocortical carcinoma (ACC) of  LRA and 2 ACC 
of  OA. Because this type of  adrenal tumor is considered 
a malignant mass, the ACC in LRA group was convert-
ed to HARA. The remaining two cases were respectively 
diagnosed as adrenal medullary hyperplasia and myeloli-
poma. Total adrenalectomies were performed in 41 cases 
(61.2%). There were no significant differences between 
the two groups in all the basic characteristics (P > 0.05). 
Table 1 depicts the difference of  basic characteristics be-
tween groups.
Operative terms comparison
Table 2 lists details on operative variables of  two groups. 
The mean operation time for LRA was 98.7±32.3 min, 
while this time in OA group was 152.7±72.3 min, the dif-
ference between the groups was significant (P= 0.001). 
Estimated blood loss (EBL) was 31.9±20.0 ml for LRA 
and 590.0±1181.1 ml for OA (P= 0.03). There was no 
complication in LRA group, while one patient in OA 
group had high fever after operation, and the temperature 
dropped to normal after use of  antibiotics. The differ-
ence of  complication was not significant (P= NS). The 
post-operative hospitalization in LRA was 7.4±2.8 days, 
and this was shorter than 9.8±2.7 days in OA group (P= 
0.00). The time to first oral intake and ambulation for 
LRA was shorter than OA (first oral intake, 1.9±0.8 days 
vs 3.1±1.3 days, P= 0.00; time to ambulation, 2.6±1.4 
days vs 4.2±1.6 days, P= 0.00). While the difference be-
tween groups were not significant in terms of  ICU con-
version (3/41 vs 4/26, P= NS) and duration of  drain 
(3.9±2.2 days vs 4.7±1.9 days, P= NS).
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Table 4 Studies on the laparoscopic adrenalectomy for tumors larger than 5cm 
 
Fisrt Author Year Origin country Patients† Compare outcome 
Brix 2010 Germany 
OA 117 
Lap is not inferior to OA for adrenal tumor ≤10 cm Lap 35 
Poripiglia 2010 Italy 
OA 25 
No differences in terms of survival time were noted Lap 18 
Miller 2010 USA 
OA 71 
Lap is inferior to OA for adrenal tumor Lap 17 
Mir 2012 USA 
OA 26 
Lap is inferior to OA for adrenal tumor Lap 18 
Gonzalez 2005 USA 
OA 133 
Lap is inferior to OA for adrenal tumor Lap 6 
Bozkurt 2015 Turkey 
Lap ≥8cm 
16 LA is safe and effective for adrenal tumor <15 cm Lap <8cm 
19 
Feo 2015 Italy 
Lap ≥5cm 
50 ≥5cm prolonged hospital stay (HR 0.67; 95 % CI 0.47-0.97) Lap <5cm 
150 
Feo 2015 Italy 
Lap ≥8cm 
15 ≥8cm prolonged operative time (HR 0.47; 95 % CI 0.24-0.94) Lap <8cm 
185 
Donatini 2014 France 
OA 21 
Lap is not inferior to OA for adrenal tumor ≤10 cm Lap 13 
Cooper 2013 USA 
OA 46 
Lap is inferior to OA for adrenal tumor Lap 46 
Fossa 2013 Norway 
OA 15 Lap is inferior to OA in short-term and similar with OA in long-term 
for adrenal tumor Lap 17 
Lombardi 2012 Italy 
OA 126 
Lap is not inferior to OA for adrenal tumor Lap 30 
Levoulleux 2010 France 
OA 58 
Lap is inferior to OA for adrenal tumor Lap 6 
              
               † OA, Open adrenalectomy; Lap, Laparoscopic adrenalectomy 
Correlation of  diameter and operation variables
We performed the curve estimation to investigate the 
correlation of  diameter and each operation variable. The 
result presented that tumor diameter was positively cor-
relation with estimated blood loss (R= 0.68, P< 0.01), 
operation time (R=0.46, P=0.00) and duration of  drain 
(R= 0.26, P= 0.04) in the estimating model. However, 
the tumor diameter was not associated with the hospital-
ization, time to ambulation and first oral intake (P>0.05). 
Table 3 summarizes the adjusted correlation index and its 
P value of  entire estimation.
Table 3. Correlation between diameter and each operation variable 
 
Variable R2 R P value 
Operation time 0.21 0.46 <0.001 
Estimated blood loss 0.46 0.68 <0.001 
Hospitalization 0.01 0.12 0.41 
Duration of drain 0.07 0.26 0.04 
Fist oral intake 0.01 0.11 0.25 
Time to ambulation 0.01 0.09 0.19 
          
          R2, adjusted coefficient of determination; R, adjusted correlation index 
Studies on laparoscopic adrenalectomy versus open 
procedure
We also retrieved studies that focused on the laparoscop-
ic adrenalectomy (LA) for large adrenal tumors. A total 
of  9 studies15-24 mentioned the comparison on LA and 
OA, and two studies25,26 mentioned different diameter 
of  adrenal tumor in LA. There exists controversy on the 
advantages of  laparoscopy, as shown in the summarized 
information of  related studies listed in Table 4.
Discussion
Adrenal surgery has been a high-risk operation in urol-
ogy for a long time. Due to the special location of  the 
adrenals, even when dealing with a small diameter adrenal 
tumor, it needs a large incision and high position to car-
ry out the operation27. This method has not only caused 
great trauma to patients, but also significantly improves 
the proportion of  pleural lesions and surgical complica-
African Health Sciences Vol 17 Issue 1, March, 2017297
tions. Most important adrenal vasculature can only be li-
gated through blind separation and hand feeling for the 
reason that most adrenals could show difficulties; this in-
creased the probability of  tissue injury and hemorrhage28. 
Laparoscopic adrenal surgery could be a finer and conve-
nient operation. It can clearly separate the important ves-
sels under a direct vision. This technique can significantly 
decrease the post-operative complications29.
There are many methods of  minimally invasive surger-
ies in the management of  adrenal tumors. According to 
the different surgical approaches, they can be divided 
into transperitoneal and retroperitoneal laparoscopy ad-
renalectomy (RLA)30. Advantages and disadvantages have 
been reported on the transperitoneal and retroperitoneal 
adrenalectomy. The transperitoneal approach can bene-
fit from more visibility and larger working space, as well 
as most familiar anatomy for surgeons. Previous opinion 
shows that TLA is better than RLA in the treatment of  
large adrenal tumors (> 5 cm). However, in TLA, there is 
need to mobilize intra-abdominal structures and organs, 
which has a high risk for organ or vascular injury. The 
complications of  TLA also include prolonged ileus and 
the risk of  adhesion formation. In the treatment of  pa-
tients who received previous abdominal surgery, the TLA 
is especially difficult to perform. While RLA owns obvi-
ous advantages, as it has a more direct route and doesnot 
interfere with the intra-abdominal organs. In our previous 
research, we identified that the operative time in RLA is 
shorter than TLA30. With the development of  minimally 
invasive surgery, scholars constantly show that the large 
adrenal tumor can also benefit from RLA approach.
In the RLA, we can also divide it in lateral, posterior and 
anterior approach. Since Zhang el al31 made the lateral 
retroperitonoscopic adrenalectomy (LRA) promotion 
and standardization, it has been the most common meth-
od in dealing with adrenal tumor in China. In our expe-
rience, even though the retroperitoneal approach is diffi-
cult, it is beneficial in the post-operative recovery. Since 
the improvement of  laparoscopic instruments and pro-
ficiency of  operation skill, the tumor diameter may not 
be the major restricting factor32. While, there were dis-
crepant opinions on the application of  laparoscope in the 
management of  large (> 5cm) adrenal tumor33,34. The aim 
of  the present study was to compare the results of  LRA 
and OA in the management of  large adrenal tumors (> 
5cm). The results revealed that the LRA was superior to 
OA in terms of  operation time, intraoperative blood loss, 
post-operative hospitalization, complication, first oral in-
take and time to ambulation. There were three patients in 
LRA group and 4 patients in OA group who converted to 
ICU. Among these patients, five cases were pheochromo-
cytoma (PHEO), with unstable blood pressure. Abnor-
mal blood vessels and huge volume can always be found 
in PHEO cases. Additionally, catchecholamines would 
be overly secreted during the tumor disturbance35. Both 
these features could lead to sharp fluctuations in blood 
pressure and heart rate, and increase the risk of  bleeding.
The complication of  LRA was around 11.5%, and includ-
ed adrenal cataclastic, peritoneal injury, vena cava and re-
nal vein injury36. In addition, the hypercapnia and pneu-
moderm which are caused by high pressure of  CO2 or the 
shallowly insertion of  Trocar can also happen37. Usually, 
the CO2 insufflation pressure was proper when between 
12 and 15 cmH2O according to our experience. Studies 
showed that these complications were mainly related with 
learning curve and different surgeons38,39.
Bleeding in LRA will inevitably be less with a small inci-
sion and slightly tissue injury. Our experience suggested 
that we can inject approximately 350 ml normal saline 
into a self-made gasbag to expand the potential peritoneal 
cavity. Then followed by 3 minutes’ compression in order 
to prevent the bleeding caused by small blood vessel rup-
ture. In addition, ultrasonic knife could be widely used in 
the solidification of  small blood vessels during the sepa-
ration of  renal fascia and adipose capsule. However, open 
surgery hemostasis would be chosen without any hesita-
tion when the operating vision was influenced by adrenal 
cataclastic or unmanageable vascular injury40.
Limitations
There were certain limitations of  LRA that we need to 
take into consideration. The restricted potential cavity 
limited the diameter of  removable tumor. The interac-
tion of  surgical instruments could also obviously affect 
the ease of  operation. Many scholars have reported that 
the retroperitoneal laparoscope could just be used in the 
small- to medium-sized benign adrenal tumor41. How-
ever, the evidence from our present study has removed 
this restriction. Moreover, the normal anatomic marks of  
peritoneal cavity would be disturbed by the use of  gasbag, 
which was usually used to expand the peritoneal cavity. 
This may also enhance the difficulty of  operation. More 
importantly, the effect of  gas bag extrusion could also 
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make the tumor over-secret catchecholamines in PHEO 
cases, therefore the pre-operative blood pressure and 
sphygmus control are very important42.
In summary, LRA provides a new way of  minimally in-
vasive surgery for the surgical treatment of  the adrenal 
disease. It was superior to open surgery in management 
of  large adrenal tumors, in terms of  operation time, in-
traoperative blood loss and post-operative recovery. Our 
result has strengthened the opinion that there is availabil-
ity of  LRA for adrenal tumor greater than 5 centimeters. 
Uro-surgeons or endocrinology surgeons could take LRA 
into consideration when they deal with large adrenal tu-
mors.
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